Spotify renews deal with podcaster Joe Rogan, will put show on other platforms

Spotify renews deal with podcaster Joe Rogan, will put show on other platforms


Podcaster and comedian Joe Rogan.

Vivian Zink | SYFY | NBCUniversal

Spotify has signed a new blockbuster deal with polarizing podcaster and comedian Joe Rogan, but this time, his show won’t be exclusive to Spotify, the company announced Friday in a news release.

The multiyear deal with Rogan, the founder of “The Joe Rogan Experience,” is said to be worth about $250 million, according to The Wall Street Journal, which first reported on the deal. The show was the No. 1 podcast in the U.S. for the third quarter of last year, according to Edison Research.

Spotify also said it’s expanding the partnership to allow the show to be available on other platforms. Shares of the audio streaming giant rose roughly 1.5% Friday.

Spotify first brought “The Joe Rogan Experience” to its platform exclusively in 2020 in a deal that was reportedly worth more than $100 million.

The talk-show style podcast is known — and often criticized for — its edgy approach and guests. Last year, for example, Tesla CEO Elon Musk appeared on the show and said he bought social media site X to save it from the “woke mind virus.”

Rogan faced backlash in 2022 after a compilation of videos surfaced of him using the N-word. He was also chastised by medical professionals and others for spreading Covid-19 misinformation and conspiracy theories.

Spotify came under fire for hosting those videos, and dozens of Rogan’s episodes were removed from the platform. Musicians including Neil Young and Joni Mitchell also pulled their music libraries from Spotify in protest.

Don’t miss these stories from CNBC PRO:



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More